- Home
- PAY vs RNA Comparison
PAY vs RNA Comparison
Compare PAY & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAY
- RNA
- Stock Information
- Founded
- PAY 2004
- RNA 2012
- Country
- PAY United States
- RNA United States
- Employees
- PAY N/A
- RNA N/A
- Industry
- PAY Computer Software: Prepackaged Software
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- PAY Technology
- RNA Health Care
- Exchange
- PAY Nasdaq
- RNA Nasdaq
- Market Cap
- PAY 4.7B
- RNA 4.4B
- IPO Year
- PAY 2021
- RNA 2020
- Fundamental
- Price
- PAY $34.21
- RNA $31.82
- Analyst Decision
- PAY Hold
- RNA Strong Buy
- Analyst Count
- PAY 6
- RNA 11
- Target Price
- PAY $28.80
- RNA $64.36
- AVG Volume (30 Days)
- PAY 523.2K
- RNA 1.4M
- Earning Date
- PAY 11-12-2024
- RNA 11-07-2024
- Dividend Yield
- PAY N/A
- RNA N/A
- EPS Growth
- PAY 201.39
- RNA N/A
- EPS
- PAY 0.32
- RNA N/A
- Revenue
- PAY $778,668,000.00
- RNA $10,117,000.00
- Revenue This Year
- PAY $37.66
- RNA N/A
- Revenue Next Year
- PAY $22.59
- RNA N/A
- P/E Ratio
- PAY $107.10
- RNA N/A
- Revenue Growth
- PAY 33.82
- RNA N/A
- 52 Week Low
- PAY $14.77
- RNA $8.86
- 52 Week High
- PAY $38.94
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- PAY 51.88
- RNA 31.67
- Support Level
- PAY $32.59
- RNA $30.07
- Resistance Level
- PAY $35.98
- RNA $34.35
- Average True Range (ATR)
- PAY 1.83
- RNA 2.21
- MACD
- PAY -0.61
- RNA -0.47
- Stochastic Oscillator
- PAY 37.06
- RNA 15.36
About PAY Paymentus Holdings Inc.
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.